EM2301E "Teaching the Old Dog New Tricks: Efforts to Reform Clinical Trial Design and Conduct" (IM GR-012723)
Purpose and Overview
Clinical trials offer patients access to promising therapies, answer important clinical questions, and lead to new and better treatments. However, stringent eligibility criteria, complex study procedures, and other factors limit trial enrollment, thereby increasing costs, decreasing generalizability of results, and delaying medical advances. Recent efforts from investigators, advocacy organizations, and regulatory authorities have addressed many of these inefficiencies.
Target Audience
physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Appreciate the development and impact of clinical trial eligibility criteria.
- Understand factors that may limit the activation of clinical trials at sites providing care to diverse populations.
- Identify changes to clinical trial practice allowed by U.S. regulatory authorities during the COVID-19 public health emergency.
David Gerber, M.D.
Professor of Internal Medicine
Co-Director of Experimental Therapeutics Program
Division of Hematology/Oncology
Available Credit
- 1.00 AMA
Price
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome